Canopy Growth (CGC) Operating Leases (2017 - 2026)
Canopy Growth (CGC) reported Operating Leases of $22.6 million for Q1 2026, up 16.84% on a YoY basis from $19.4 million in Q1 2025, and up 82.64% sequentially from $12.4 million in Q4 2025.
Canopy Growth (CGC) Operating Leases (2017 - 2026) Analysis & Trends
Canopy Growth (CGC) has 9 years of Operating Leases data on file, last reported at $22.6 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases rose 16.84% year-over-year to $22.6 million; the trailing twelve-month figure through Mar 2026 stood at $22.6 million (up 16.84% YoY), and the FY2026 full-year result was $22.6 million, up 16.84% from the prior year.
- Operating Leases grew to $22.6 million in Q1 2026, from $12.4 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $79.8 million in Q1 2022 to a low of $12.4 million in Q4 2025.
- A 5-year average of $39.7 million and a median of $41.3 million in 2024 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases sank 75.37% in 2024 and grew 16.84% in 2026, its largest moves.
- Tracing CGC's Operating Leases over 5 years: stood at $61.3 million in 2022, then slipped by 19.47% to $49.3 million in 2023, then sank by 57.17% to $21.1 million in 2024, then plunged by 41.39% to $12.4 million in 2025, then surged by 82.64% to $22.6 million in 2026.
- Business Quant data shows CGC's Operating Leases at $22.6 million in Q1 2026, $12.4 million in Q4 2025, and $13.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.63 Mn |
| Dec 31, 2025 | 12.39 Mn |
| Sep 30, 2025 | 13.47 Mn |
| Jun 30, 2025 | 14.35 Mn |
| Mar 31, 2025 | 19.36 Mn |
| Dec 31, 2024 | 21.13 Mn |
| Sep 30, 2024 | 12.87 Mn |
| Jun 30, 2024 | 14.20 Mn |
| Mar 31, 2024 | 41.26 Mn |
| Dec 31, 2023 | 49.34 Mn |
| Sep 30, 2023 | 52.24 Mn |
| Jun 30, 2023 | 56.14 Mn |
| Mar 31, 2023 | 57.97 Mn |
| Dec 31, 2022 | 61.27 Mn |
| Sep 30, 2022 | 69.98 Mn |
| Jun 30, 2022 | 76.81 Mn |
| Mar 31, 2022 | 79.84 Mn |
| Dec 31, 2021 | 82.74 Mn |
| Sep 30, 2021 | 71.44 Mn |
| Jun 30, 2021 | 75.80 Mn |